Search
+
    SEARCHED FOR:

    ST JUDE CHILDRENS RESEARCH HOSPITAL

    Elon Musk has a giant charity, its money stays close to home

    Musk, the world's second-richest person, according to Forbes, presides over SpaceX, Tesla and other companies that are pushing the boundaries of technology, while also controlling a social media platform, now known as X, formerly Twitter, through which he promotes his often-polarizing political and social views.

    Israel vows to fight on in Gaza despite deadly ambush and rising international pressure

    Amid escalating conflict, Israel pledges to continue fighting Hamas in Gaza despite international calls for a ceasefire and U.S. unease. Hamas' resilience challenges Israel's aim to crush it without devastating Gaza. The ongoing offensive has led to significant civilian casualties and massive displacement. While casualties rise, support for Hamas among Palestinians grows, reflecting dissatisfaction with leadership and intensifying the conflict's complexity. Israel and Hamas remain at odds, with little prospect of swift resolution.

    Streamy Awards 2023: MrBeast receives Creator of Year award, full list of winners, categories, host

    Know about Michelle Khare and the winners in all categories of the 2023 Streamy Awards.

    Legacy of Love: Whitney Houston's estate announces 2nd annual gala with BeBe Winans, Kim Burrell

    The estate of Whitney Houston, Sony, and Primary Wave Music will host the 2nd annual Whitney Houston Legacy of Love on Aug. 9 for the late singer's 60th birthday. The gala will benefit her foundation aimed at helping young people.

    On Dhirubhai Ambani's 21st death anniversary, daughters-in-law pay tribute: Tina remembers 'true visionary', Nita gets nostalgic about daily quizzing sessions

    Tina Ambani, Chairperson of Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, paid tribute to her father-in-law, Dhirubhai Ambani, on his 21st death anniversary. She called him a visionary and highlighted that he was ahead of his time.

    mRNA booster vaccine Gemcovac-OM for Omicron launched at Rs 2,292/dose. Who can take and precautions

    Gemcovac-OM, the booster vaccine for Omicron from Emcure's subsidiary Gennova, had recently received the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). Individuals above 18 years and who have received either Covaxin or Covishield as primary vaccination can take it as a booster for active immunization for the prevention of COVID-19.

    The Economic Times
    BACK TO TOP